Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer

Janine M DeBlasi1,2, Gina M DeNicola1

  • 1Department of Cancer Physiology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.

Cancers
|October 21, 2020
PubMed

Insights

The transcription factor NRF2 (nuclear factor-erythroid 2 p45-related factor 2) regulates cellular responses to stress and metabolism. This review explores how NRF2 and its regulator KEAP1 (Kelch-like ECH-associated protein 1) interact with metabolic pathways.

Area of Science:

  • Cellular Biology
  • Metabolism
  • Molecular Biology

Background:

  • The transcription factor NRF2 (nuclear factor-erythroid 2 p45-related factor 2) is a key regulator of cellular antioxidant responses.
  • NRF2 activation leads to increased glutathione and decreased reactive oxygen species (ROS).
  • Emerging evidence highlights NRF2's role in modulating metabolic processes crucial for cell proliferation and survival.

Purpose of the Study:

  • To review the intricate interplay between the NRF2/KEAP1 complex and cellular metabolism.
  • To discuss how metabolic pathway perturbations influence NRF2 stabilization.
  • To explore NRF2-mediated metabolic adaptations to cellular stress.

Main Methods:

  • Literature review focusing on NRF2, KEAP1, and metabolic pathways.
  • Analysis of NRF2's regulation of key metabolic pathways like the pentose phosphate pathway, glutaminolysis, and lipid metabolism.
  • Examination of NRF2-independent mechanisms of KEAP1 in metabolism.

Main Results:

  • NRF2 regulates metabolic pathways (pentose phosphate pathway, NADPH production, glutaminolysis, lipid/amino acid metabolism) often exploited by cancer cells.
  • Metabolic deregulation in normal and cancer physiology can stabilize NRF2.
  • Perturbations in TCA cycle, glycolysis, and autophagy can lead to NRF2 stabilization, which in turn helps cells manage metabolic stress.

Conclusions:

  • The NRF2/KEAP1 complex is deeply integrated with cellular metabolic processes.
  • Understanding this interplay is crucial for comprehending both normal physiology and cancer progression.
  • KEAP1 may exert metabolic influence beyond its canonical role in NRF2 regulation.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
17.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.2K